- News Home
6 March 2014 1:04 pm ,
Vol. 343 ,
Antiretroviral drugs can protect people from becoming infected by HIV. But so-called pre-exposure prophylaxis, or PrEP...
Two studies show that eating a diet low in protein and high in carbohydrates is linked to a longer, healthier life, and...
Considered an icon of conservation science, researchers at World Wildlife Fund (WWF) headquarters in Washington, D.C.,...
The new atlas, which shows the distribution of important trace metals and other substances, is the first product of...
Early in April, the first of a fleet of environmental monitoring satellites will lift off from Europe's spaceport in...
Since 2000, U.S. government health research agencies have spent almost $1 billion on an effort to churn out thousands...
Magdalena Koziol, a former postdoc at Yale University, was the victim of scientific sabotage. Now, she is suing the...
- 6 March 2014 1:04 pm , Vol. 343 , #6175
- About Us
'Immortality Enzyme' Could Trigger Cancer
15 June 2000 5:00 pm
An enzyme that can make cells live forever has been touted as a key to understanding aging and treating diseases from AIDS to diabetes. However, the enzyme may also turn on a gene that stimulates cancer, researchers report in the 15 June issue of Nature. Other researchers worry that the finding may be due to laboratory artifacts.
Telomerase immortalizes cells by protecting the tips of their chromosomes, which are known as telomeres. Telomeres dictate how many times a cell can divide: With each division, a bit of these chromosome caps chips away. When the caps are gone, the cell can no longer replicate. Telomerase rebuilds the telomeres and allows cells to divide--potentially forever. So scientists hope to use the enzyme to grow unlimited amounts of human cells in culture, including skin cells for burn victims, insulin-secreting cells for diabetics, and new white blood cells for AIDS patients. But some researchers fear that telomerase could make cells divide uncontrollably. Indeed, the enzyme is present in nearly all cancer cells, but isn't found in most normal mature cells, which suggests that telomerase might trigger unfettered cell multiplication.
To investigate this possibility, molecular biologist David Beach of University College, London, and two colleagues in the United States grew human breast epithelial cells in a culture. Then they infected them with a virus carrying the telomerase gene. As expected, the cells incorporated the gene and were still going strong after 250 divisions, about four times their normal life span. But during cell growth the activity of another gene called c-myc jumped two to three times higher than normal. This gene is cranked up in several kinds of cancers, including breast cancer and some lymphomas, so although the cultured cells probably weren't cancerous, Beach says, they had taken an ominous step in that direction.
The results show that researchers must know more about how cells age before they can safely use telomerase to grow replacement tissue, Beach says. But cell biologist Jerry Shay of the University of Texas Southwestern Medical Center in Dallas thinks that the cancer gene may have been turned on simply because of the way the cells were grown in the laboratory. Shay says this could be a case of "much ado about tissue culture artifacts."